# Natsar Pharmaceuticals, Inc. — Form D

Natsar Pharmaceuticals, Inc. of ELLICOTT CITY, MD, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-08. $4.2M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2026-05-08
- Form: D
- Accession: 0002134002-26-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $4.2M
- Minimum investment: $1
- Investors: 15
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-583294

## Issuer

- Name: Natsar Pharmaceuticals, Inc.
- CIK: 0002134002
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 4624 TALL MAPLE CT., ELLICOTT CITY, MD, 21043
- Phone: 410-948-2578

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Venu Raman | Related Person | Ellicott City, MD |

## More

- [CIK 2134002 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2134002&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002134002-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.
